Joseph‐Anthony Tan

522 total citations
14 papers, 406 citations indexed

About

Joseph‐Anthony Tan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Joseph‐Anthony Tan has authored 14 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 2 papers in Physiology. Recurrent topics in Joseph‐Anthony Tan's work include Cystic Fibrosis Research Advances (7 papers), Ion Transport and Channel Regulation (5 papers) and Neonatal Respiratory Health Research (4 papers). Joseph‐Anthony Tan is often cited by papers focused on Cystic Fibrosis Research Advances (7 papers), Ion Transport and Channel Regulation (5 papers) and Neonatal Respiratory Health Research (4 papers). Joseph‐Anthony Tan collaborates with scholars based in United States, Canada and Italy. Joseph‐Anthony Tan's co-authors include Peter M. Haggie, Puay‐Wah Phuan, A. S. Verkman, Walter E. Finkbeiner, Lorna Zlock, A.S. Verkman, Onur Çil, Dennis W. Nielson, Jing Song and Linda K. Durrin and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Scientific Reports.

In The Last Decade

Joseph‐Anthony Tan

14 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph‐Anthony Tan United States	10	230	220	42	33	22	14	406
Stan Pasyk Canada	9	272 1.2×	154 0.7×	30 0.7×	20 0.6×	16 0.7×	10	342
Thomas J. Kelley United States	11	379 1.6×	281 1.3×	131 3.1×	47 1.4×	48 2.2×	18	630
Yong Zou China	10	140 0.6×	196 0.9×	26 0.6×	40 1.2×	64 2.9×	16	448
Kate J. Treharne United Kingdom	9	167 0.7×	193 0.9×	36 0.9×	29 0.9×	15 0.7×	15	336
Kevin Muñoz Forti United States	10	36 0.2×	104 0.5×	91 2.2×	38 1.2×	19 0.9×	16	293
Qing Luo China	9	77 0.3×	150 0.7×	84 2.0×	41 1.2×	13 0.6×	21	322
Yiping Dong China	13	59 0.3×	239 1.1×	15 0.4×	91 2.8×	34 1.5×	30	403
Ángel G. Valdivieso Argentina	14	272 1.2×	232 1.1×	65 1.5×	23 0.7×	49 2.2×	22	481
Eric Patterson United States	9	55 0.2×	224 1.0×	40 1.0×	77 2.3×	75 3.4×	16	357

Countries citing papers authored by Joseph‐Anthony Tan

Since Specialization

Citations

This map shows the geographic impact of Joseph‐Anthony Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph‐Anthony Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph‐Anthony Tan more than expected).

Fields of papers citing papers by Joseph‐Anthony Tan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph‐Anthony Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph‐Anthony Tan. The network helps show where Joseph‐Anthony Tan may publish in the future.

Co-authorship network of co-authors of Joseph‐Anthony Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph‐Anthony Tan. A scholar is included among the top collaborators of Joseph‐Anthony Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph‐Anthony Tan. Joseph‐Anthony Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Haggie, Peter M., et al.. (2023). Selective isoxazolopyrimidine PAT1 (SLC26A6) inhibitors for therapy of intestinal disorders. RSC Medicinal Chemistry. 14(11). 2342–2347. 2 indexed citations

Çil, Onur, Marc O. Anderson, Lívia de Souza Gonçalves, et al.. (2023). Small molecule inhibitors of intestinal epithelial anion exchanger SLC26A3 (DRA) with a luminal, extracellular site of action. European Journal of Medicinal Chemistry. 249. 115149–115149. 9 indexed citations

Çil, Onur, et al.. (2021). SLC26A6-selective inhibitor identified in a small-molecule screen blocks fluid absorption in small intestine. JCI Insight. 6(11). 11 indexed citations

Phuan, Puay‐Wah, Joseph‐Anthony Tan, Lorna Zlock, et al.. (2019). Nanomolar-potency ‘co-potentiator’ therapy for cystic fibrosis caused by a defined subset of minimal function CFTR mutants. Scientific Reports. 9(1). 17640–17640. 47 indexed citations

Zhu, Jie, Joseph‐Anthony Tan, Puay‐Wah Phuan, et al.. (2019). Synthesis and evaluation of tetrahydropyrazolopyridine inhibitors of anion exchange protein SLC26A4 (pendrin). Bioorganic & Medicinal Chemistry Letters. 29(16). 2119–2123. 2 indexed citations

Phuan, Puay‐Wah, Jung‐Ho Son, Joseph‐Anthony Tan, et al.. (2018). Combination potentiator (‘co-potentiator’) therapy for CF caused by CFTR mutants, including N1303K, that are poorly responsive to single potentiators. Journal of Cystic Fibrosis. 17(5). 595–606. 47 indexed citations

Haggie, Peter M., et al.. (2018). SLC26A3 inhibitor identified in small molecule screen blocks colonic fluid absorption and reduces constipation. JCI Insight. 3(14). 42 indexed citations

Phuan, Puay‐Wah, Guido Veit, Joseph‐Anthony Tan, et al.. (2018). ΔF508-CFTR Modulator Screen Based on Cell Surface Targeting of a Chimeric Nucleotide Binding Domain 1 Reporter. SLAS DISCOVERY. 23(8). 823–831. 5 indexed citations

Lee, Sujin, Puay‐Wah Phuan, Christian Félix, et al.. (2017). Nanomolar-Potency Aminophenyl-1,3,5-triazine Activators of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Chloride Channel for Prosecretory Therapy of Dry Eye Diseases. Journal of Medicinal Chemistry. 60(3). 1210–1218. 18 indexed citations

10.

Haggie, Peter M., Puay‐Wah Phuan, Joseph‐Anthony Tan, et al.. (2016). Correctors and Potentiators Rescue Function of the Truncated W1282X-Cystic Fibrosis Transmembrane Regulator (CFTR) Translation Product. Journal of Biological Chemistry. 292(3). 771–785. 72 indexed citations

11.

Çil, Onur, Peter M. Haggie, Puay‐Wah Phuan, Joseph‐Anthony Tan, & A.S. Verkman. (2016). Small-Molecule Inhibitors of Pendrin Potentiate the Diuretic Action of Furosemide. Journal of the American Society of Nephrology. 27(12). 3706–3714. 36 indexed citations

12.

Haggie, Peter M., Puay‐Wah Phuan, Joseph‐Anthony Tan, et al.. (2016). Inhibitors of pendrin anion exchange identified in a small molecule screen increase airway surface liquid volume in cystic fibrosis. The FASEB Journal. 30(6). 2187–2197. 43 indexed citations

13.

Tan, Joseph‐Anthony, Jing Song, Yuan Chen, & Linda K. Durrin. (2010). Phosphorylation-Dependent Interaction of SATB1 and PIAS1 Directs SUMO-Regulated Caspase Cleavage of SATB1. Molecular and Cellular Biology. 30(11). 2823–2836. 34 indexed citations

14.

Tan, Joseph‐Anthony, Yujie Sun, Jing Song, et al.. (2008). SUMO Conjugation to the Matrix Attachment Region-binding Protein, Special AT-rich Sequence-binding Protein-1 (SATB1), Targets SATB1 to Promyelocytic Nuclear Bodies Where It Undergoes Caspase Cleavage. Journal of Biological Chemistry. 283(26). 18124–18134. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact